Pliant Therapeutics
Stock Forecast, Prediction & Price Target
Pliant Therapeutics Financial Estimates
Pliant Therapeutics Revenue Estimates
Pliant Therapeutics EBITDA Estimates
Pliant Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $7.57M N/A | $9.68M 27.90% | $1.58M -83.68% | Avg: $6.29M Low: $6.29M High: $6.29M avg. 298.62% | Avg: $3.65M Low: $3.65M High: $3.65M avg. -41.92% | Avg: $46.46M Low: $46.46M High: $46.46M avg. 1170.27% | Avg: $166.19M Low: $166.19M High: $166.19M avg. 257.67% |
Net Income
% change YoY
| $-17.90M N/A | $-121.49M -578.49% | $-161.33M -32.78% | Avg: $-245.76M Low: $-261.29M High: $-195.53M avg. -52.33% | Avg: $-274.74M Low: $-291.83M High: $-161.47M avg. -11.79% | Avg: $-190.51M Low: $-190.51M High: $-190.51M avg. 30.65% | Avg: $-105.18M Low: $-105.18M High: $-105.18M avg. 44.79% |
EBITDA
% change YoY
| $-19.98M N/A | $-122.53M -513.07% | $-158.22M -29.13% | Avg: $-5.03M Low: $-5.03M High: $-5.03M avg. 96.81% | Avg: $-2.92M Low: $-2.92M High: $-2.92M avg. 41.92% | Avg: $-37.15M Low: $-37.15M High: $-37.15M avg. -1170.27% | Avg: $-132.89M Low: $-132.89M High: $-132.89M avg. -257.67% |
EPS
% change YoY
| -$0.5 N/A | -$2.89 -478% | -$2.75 4.84% | Avg: -$3.77 Low: -$4.45 High: -$3.33 avg. -37.04% | Avg: -$3.84 Low: -$4.97 High: -$2.75 avg. -1.98% | Avg: -$3.24 Low: -$3.24 High: -$3.24 avg. 15.59% | Avg: -$1.79 Low: -$1.79 High: -$1.79 avg. 44.79% |
Operating Expenses
% change YoY
| $27.55M N/A | $136.88M 396.71% | $185.72M 35.67% | Avg: $56.72M Low: $56.72M High: $56.72M avg. -69.45% | Avg: $32.94M Low: $32.94M High: $32.94M avg. -41.92% | Avg: $418.49M Low: $418.49M High: $418.49M avg. 1170.27% | Avg: $1.49B Low: $1.49B High: $1.49B avg. 257.67% |
FAQ
What is Pliant Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 2.83% in 2025-2028.
We have gathered data from 10 analysts. Their low estimate is -261.29M, average is -245.76M and high is -195.53M.
What is Pliant Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 421.16% in 2025-2028.
We have gathered data from 10 analysts. Their low revenue estimate is $6.29M, average is $6.29M and high is $6.29M.
What is Pliant Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 5.33% in 2025-2028.
We have gathered data from 10 analysts. Their low earnings per share estimate is -$4.45, average is -$3.77 and high is $-3.33.
What is the best performing analyst?
In the last twelve months analysts have been covering Pliant Therapeutics stock. The most successful analyst is Yasmeen Rahimi.